Views & Analysis Digital Health Round-Up: Novartis and Science 37 hope to cut... Richard Staines presents a round-up of the week’s digital health news
News Mental health startup NeuroFlow wins digital health challeng... NeuroFlow, a startup company focused on technology to support people with mental health issues has won a digital health challenge set by Otsuka.
News Novartis to develop digital therapies with Pear Deal covers digital therapies for MS and schizophrenia
News Janssen's depression drug shows promise in phase 2 Ketamine may be best known as an anaesthetic illegally used as a party drug, but Janssen has shown that it could also be reformulated and used as a treatment for depression.
News Otsuka recruits Medibio to pinpoint mental health biomarkers Medibio's technology will be used to gather mental health biomarkers related to Otsuka's Abilify.
R&D SpringWorks spins out of Pfizer on rare disease mission A new biotech spun out of Pfizer is to develop four drugs for rare and serious diseases.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.